Skip to content
10-Q

Quarterly Report

MJ BIOTECH, INC.

0001543272-18-000048

← back to feed
Filed
Nov 16, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Nov 6, 2018 53.35M sh
Shares Diluted Q2 2018 · Jun 30, 2018 724.39M sh
Shares Diluted Q2 2018 · Jun 30, 2018 44.7M sh
Shares Diluted Q2 2018 · Jun 30, 2017 20.76M sh
Shares Diluted restated Q2 2018 · Jun 30, 2017 2.38M sh
Cash And Equivalents Q2 2018 · Jun 30, 2018 $154
Cash And Equivalents Q2 2018 · Dec 31, 2017 $82
Cash And Equivalents restated Q2 2018 · Jun 30, 2017 $0
Cash And Equivalents Q2 2018 · Dec 31, 2016 $26.77K
Stockholders Equity Q2 2018 · Jun 30, 2018 −$3.17M
Stockholders Equity Q2 2018 · Dec 31, 2017 −$1.8M
Current Liabilities Q2 2018 · Jun 30, 2018 $3.17M
Current Liabilities Q2 2018 · Dec 31, 2017 $1.8M
Total Liabilities Q2 2018 · Jun 30, 2018 $3.17M
Total Liabilities Q2 2018 · Dec 31, 2017 $1.8M
Current Assets Q2 2018 · Jun 30, 2018 $154
Current Assets Q2 2018 · Dec 31, 2017 $82
Total Assets Q2 2018 · Jun 30, 2018 $154
Total Assets Q2 2018 · Dec 31, 2017 $82
Sga Expense Q2 2018 · Jun 30, 2018 $17.03K
Sga Expense Q2 2018 · Jun 30, 2018 $46.4K
Sga Expense Q2 2018 · Jun 30, 2017 $208.6K
Sga Expense Q2 2018 · Jun 30, 2017 $80.96K
Operating Income Q2 2018 · Jun 30, 2018 −$56.93K
Operating Income Q2 2018 · Jun 30, 2018 −$118.62K
Operating Income Q2 2018 · Jun 30, 2017 −$5.75M
Operating Income Q2 2018 · Jun 30, 2017 −$80.96K
Revenue Q2 2018 · Jun 30, 2018 $0
Revenue Q2 2018 · Jun 30, 2018 $0
Revenue Q2 2018 · Jun 30, 2017 $0
Revenue Q2 2018 · Jun 30, 2017 $0